BOP1 Used as a Novel Prognostic Marker and Correlated with Tumor Microenvironment in Pan-Cancer

Figure 8

Methylation modification of BOP1 in pan-cancer. (a) The relevance between BOP1 level and promoter methylation in UVM, UCS, SARC, PRAD, BRCA, and ESCA. (b) The relevance between BOP1 promoter methylation level and OS in BRCA and SKCM. (c) The relevance between BOP1 promoter methylation level and DFI in KIRP. (d) The relevance between BOP1 promoter methylation level and DSS in SKCM, MESO, and SARC. (e) The relevance between BOP1 promoter methylation level and PFI in KIRP and SKCM.

(a)

(b)

(c)

(d)

(e)